Are clinical trials safe?

Yes. Every study on QualifiedStudies is reviewed and approved by an Institutional Review Board (IRB) and conducted under FDA regulations. Research sites are HIPAA-covered entities, and you can withdraw at any time for any reason.

Do I get paid to participate in a clinical trial?

Most studies offer compensation for your time and travel. The amount varies by study length and visit schedule, and is disclosed up front before you enroll.

Is my health information kept private?

Yes. Your information is encrypted, never sold, and only shared with the specific research site you choose to apply to. Our handling of your data is governed by our Consumer Health Data Privacy Policy; the research sites you're matched with are HIPAA-covered entities.

How do I qualify for a clinical trial?

Take our free 60-second eligibility quiz. Enter your ZIP code, condition, and a few health details, and we'll match you with research sites near you that are actively enrolling participants.

A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis

NCT ID: NCT07412704
Registry status: Recruiting
Study type: Interventional
Phase: Phase 1 / Phase 2
Sponsor: Bristol-Myers Squibb
Conditions: Arthritis, Rheumatoid

Overview

ClinicalTrials.gov lists this study as Recruiting.

Official title: A Phase 1/2a, Open-label, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of BMS-986528 in Participants With Refractory Rheumatoid Arthritis

Enrollment: 84 participants (Estimated).

What is being studied

Drug: BMS-986528

Who may be eligible

Ages: 18 Years to 65 Years
Sex: All
Healthy volunteers accepted: No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria \- Adult participants with rheumatoid arthritis (RA) who meet definition of difficult-to-treat. Exclusion Criteria * Juvenile arthritis or onset of inflammatory arthritis before age 18. * Seronegative RA participants in whom polymyalgia rheumatica has not been ruled out. * Active fibromyalgia with pain symptoms or signs that would interfere with joint assessment. * Other protocol-defined Inclusion/Exclusion criteria apply.

Study locations

39 study locations are listed.

Recruiting site status is explicitly provided for 39 locations; 6 are listed as Recruiting.

Countries: Belgium, Brazil, China, Germany, Italy, Mexico, Poland, Spain, Switzerland, Ukraine, United States

Flanders, Belgium: 1
Goiás, Brazil: 1
Rio Grande do Sul, Brazil: 1
São Paulo, Brazil: 1
Beijing Municipality, China: 1
Guangdong, China: 1
Henan, China: 1
Jiangxi, China: 1
Shanghai Municipality, China: 2
Bavaria, Germany: 1
Milano, Italy: 1
Masovian Voivodeship, Poland: 1
A Coruña [La Coruña], Spain: 1
Ivano-Frankivsk Oblast, Ukraine: 1
Poltava Oblast, Ukraine: 1
California, United States: 3
Colorado, United States: 2
Florida, United States: 1
New York, United States: 2
Oregon, United States: 1
Pennsylvania, United States: 1
Texas, United States: 1

Sample of listed locations

Charité Research Organisation — Berlin, 10117, Germany — Recruiting
St. Josef-Stift Sendenhorst — Sendenhorst, 48324, Germany — Recruiting
CHUAC-Complejo Hospitalario Universitario A Coruña — A Coruña, A Coruña [La Coruña], 15006, Spain — Recruiting
Hospital Universitario Reina Sofia — Córdoba, 14004, Spain — Recruiting
Universitaetsspital Bern - Inselspital — Bern, 3010, Switzerland — Recruiting
Colorado Blood Cancer Institute — Denver, Colorado, 80218, United States — Recruiting
Local Institution - 0048 — Merksem, Flanders, 2170, Belgium — Not yet recruiting
Local Institution - 0049 — Leuven, 3000, Belgium — Not yet recruiting
Local Institution - 0083 — Aparecida de Goiânia, Goiás, 74935-530, Brazil — Not yet recruiting
Local Institution - 0033 — Porto Alegre, Rio Grande do Sul, 90050-010, Brazil — Not yet recruiting
Local Institution - 0082 — Valinhos, São Paulo, 13271-130, Brazil — Not yet recruiting
Local Institution - 0006 — Beijing, Beijing Municipality, 100091, China — Not yet recruiting
Local Institution - 0080 — Guangzhou, Guangdong, 510260, China — Not yet recruiting
Local Institution - 0010 — Zhengzhou, Henan, 450000, China — Not yet recruiting
Local Institution - 0007 — Nanchang, Jiangxi, 330006, China — Not yet recruiting
Local Institution - 0001 — Shanghai, Shanghai Municipality, 200127, China — Not yet recruiting
Local Institution - 0020 — Shanghai, Shanghai Municipality, 200040, China — Not yet recruiting
Local Institution - 0040 — München, Bavaria, 81377, Germany — Not yet recruiting
Local Institution - 0021 — Cologne, 50937, Germany — Not yet recruiting
Local Institution - 0028 — Herne, 44652, Germany — Not yet recruiting
Local Institution - 0019 — Rozzano, Milano, 20089, Italy — Not yet recruiting
Local Institution - 0017 — Roma, 00168, Italy — Not yet recruiting
Local Institution - 0053 — México, 14080, Mexico — Not yet recruiting
Local Institution - 0023 — Józefów, Masovian Voivodeship, 05-410, Poland — Not yet recruiting
Local Institution - 0027 — Geneva, 1211, Switzerland — Not yet recruiting

Study details

Start date: September 15, 2026
Primary completion date: October 30, 2029
Completion date: September 2, 2030
First posted: February 17, 2026

Source and update information

Source: ClinicalTrials.gov
NCT ID: NCT07412704
Registry last updated: September 22, 2026
QualifiedStudies registry data refreshed: October 2, 2026
QualifiedStudies record fetched: October 2, 2026

View NCT07412704 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Clinical trial FAQ